Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29703908
Publication Date : //

A side-effect free method for identifying cancer drug targets.


Identifying effective drug targets, with little or no side effects, remains an ever challenging task. A potential pitfall of failing to uncover the correct drug targets, due to side effect of pleiotropic genes, might lead the potential drugs to be illicit and withdrawn. Simplifying disease complexity, for the investigation of the mechanistic aspects and identification of effective drug targets, have been done through several approaches of protein interactome analysis. Of these, centrality measures have always gained importance in identifying candidate drug targets. Here, we put forward an integrated method of analysing a complex network of cancer and depict the importance of k-core, functional connectivity and centrality (KFC) for identifying effective drug targets. Essentially, we have extracted the proteins involved in the pathways leading to cancer from the pathway databases which enlist real experimental datasets. The interactions between these proteins were mapped to build an interactome. Integrative analyses of the interactome enabled us to unearth plausible reasons for drugs being rendered withdrawn, thereby giving future scope to pharmaceutical industries to potentially avoid them (e.g. ESR1, HDAC2, F2, PLG, PPARA, RXRA, etc). Based upon our KFC criteria, we have shortlisted ten proteins (GRB2, FYN, PIK3R1, CBL, JAK2, LCK, LYN, SYK, JAK1 and SOCS3) as effective candidates for drug development.

Authors : Ashraf Md Izhar , Ong Seng-Kai , Mujawar Shama , Pawar Shrikant , More Pallavi , Paul Somnath , Lahiri Chandrajit ,

Related products :

Catalog number Product name Quantity
SENSIVUESECONDARY Drug susceptibility (secondary anti_tubercular drug) test for M.tuberculosis with a nitrate reductase assay using proportion method. One Set
SENSIVUEPRIMARY Drug susceptibility (primary anti_tubercular drug) test for M.tuberculosis with a nitrate reductase assay using proportion method. One Set
27-835 The screening of cDNA expression libraries from human tumors with serum antibody (SEREX) has proven to be a powerful method for identifying the repertoire of tumor antigens recognized by the immune sy 0.05 mg
orb61254 Imatinib (free base) Imatinib (originally STI571) is a drug used to treat certain types of cancer. For research use only. 100 mg
orb61244 Erlotinib Erlotinib hydrochloride is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer. For research use only. 100 mg
orb61256 Lapatinib (free base) Lapatinib, used in the form of lapatinib ditosylate, (USAN) (Tykerb_Tyverb, GSK) is an orally active drug for breast cancer and other solid tumours. For research use only. 100 mg
29-728 N-methylation is one method by which drug and other xenobiotic compounds are metabolized by the liver. NNMT responsible for this enzymatic activity which uses S-adenosyl methionine as the methyl donor 0.1 mg
orb61248 GDC-0449 Vismodegib is an investigational drug for the treatment of various types of cancer. For research use only. 50 mg
MR-003 ///NEW Antibody 2-Step Effect Universal Anti-Mouse_ Anti-Rabbit IgG 2-Step Effect Universal 50ml
MR-003 ///NEW Antibody 2-Step Effect Universal Anti-Mouse_ Anti-Rabbit IgG 2-Step Effect Universal 100ml
991-05-DF Saliva - Drug Free Human Donor 5 mL
991-05-DF Saliva - Drug Free Human Donor 50 mL
991-05-DF Saliva - Drug Free Human Donor 25 mL
991-05-DF SALIVA, Human - Drug Free Liquid 50 mL
991-05-DF SALIVA, Human - Drug Free Liquid 25 mL
991-05-DF SALIVA, Human - Drug Free Liquid 5 mL
orb61255 INCB018424 Ruxolitinib is a drug being investigated for the treatment of myeloproliferative diseases, plaque psoriasis, and various types of cancer. For research use only. 5 mg
orb61205 ABT-888 Veliparib (ABT-888) is a potential anti-cancer drug acting as a PARP inhibitor.It inhibits both PARP1 and PARP2. For research use only. 10 mg
EFFA-100 EnzyChrom™ Free Fatty Acid Assay Kit, Quantitative determination of free fatty acid by colorimetric (570nm) or fluorimetric (530_590nm) method 100Tests
991-03-DF Urine, Drug-Free Single Human Donor 500 mL
991-03-DF Urine, Drug-Free Single Human Donor 250 mL
991-03-DF Urine, Drug-Free Single Human Donor 50 mL
991-03-DF Urine, Drug-Free Single Human Donor 1 L
991-03-DF-P Urine, Drug Free Human Donors - Pooled 1 L
991-03-DF-P Urine, Drug Free Human Donors - Pooled 10 L


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur